Danaher Corporation (DHR)vsPrenetics Global Ltd (PRE)
DHR
Danaher Corporation
$187.15
-1.55%
HEALTHCARE · Cap: $134.43B
PRE
Prenetics Global Ltd
$21.56
-2.66%
HEALTHCARE · Cap: $361.14M
Smart Verdict
WallStSmart Research — data-driven comparison
Danaher Corporation generates 26492% more annual revenue ($24.57B vs $92.39M). DHR leads profitability with a 14.7% profit margin vs -63.1%. DHR earns a higher WallStSmart Score of 60/100 (C).
DHR
Buy60
out of 100
Grade: C
PRE
Avoid35
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-38.6%
Fair Value
$135.07
Current Price
$187.15
$52.08 premium
Intrinsic value data unavailable for PRE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Strong operational efficiency at 22.2%
Generating 1.7B in free cash flow
Reasonable price relative to book value
Areas to Watch
Premium valuation, high expectations priced in
4.6% revenue growth
ROE of 7.0% — below average capital efficiency
2.5% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -31.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : DHR
The strongest argument for DHR centers on Market Cap, Price/Book, Operating Margin. PEG of 1.23 suggests the stock is reasonably priced for its growth.
Bull Case : PRE
The strongest argument for PRE centers on Price/Book.
Bear Case : DHR
The primary concerns for DHR are P/E Ratio, Revenue Growth, Return on Equity.
Bear Case : PRE
The primary concerns for PRE are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
DHR profiles as a value stock while PRE is a turnaround play — different risk/reward profiles.
DHR carries more volatility with a beta of 0.96 — expect wider price swings.
DHR is growing revenue faster at 4.6% — sustainability is the question.
DHR generates stronger free cash flow (1.7B), providing more financial flexibility.
Bottom Line
DHR scores higher overall (60/100 vs 35/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Danaher Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.
Prenetics Global Ltd
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Prenetics Global Ltd (PRE) is a leading health technology innovator specializing in genetic and diagnostic testing, leveraging advanced technologies to provide essential health insights for consumers and healthcare professionals alike. The company boasts a comprehensive portfolio of cutting-edge genetic testing solutions and integrated digital health services, driving its robust international growth through strategic partnerships and an unwavering dedication to research and development. Positioned at the forefront of personalized medicine, Prenetics is well-equipped to meet the growing consumer demand for accessible and actionable health information, making it a compelling investment opportunity in the rapidly evolving healthcare sector.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?